Achilles Therapeutics PLC: Achilles Therapeutics Provides Bu

LONDON, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announces

Related Keywords

Germany , Chiron , Centre , France , United Kingdom , Spain , London , City Of , John Mullaly , Miraj Ali , Melissa Gardiner , Mary Jane Elliott , Sukaina Virji , Cancer Research United Kingdom , Company Tumor Archiving Program , Nasdaq , Ir External Communications , Va Research Development , Consilium Strategic Communications , Chief Executive Officer , Tumor Archiving Program , Gene Therapy , Cancer Research United , Jane Elliott , Achilles , Herapeutics , Rovides , Business , Update , Outlook , 022 ,